Want to join the conversation?
$JNJ expects an operating sales increase on a constant currency basis of between 1-2% for 2015, which would result in sales of approx. $75-76Bil. This is consistent with $JNJ's previous guidance and now reflects the impact of the divestiture of the Cordis business, offset by stronger performance in other businesses.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)